Exero Medical

Exero Medical is a medical technology company based in the US and Israel, focused on the early detection of post-operative complications, particularly after gastrointestinal surgery. Founded in 2018, the company aims to enhance patient outcomes and reduce healthcare costs by providing healthcare providers with actionable data on tissue healing. The flagship product, the xBar system, is a biodegradable wireless sensor that monitors tissue healing at the surgical site. It is designed to detect serious complications, such as anastomotic leaks, earlier than traditional methods, which often rely on clinical symptoms that appear days after surgery. The xBar system has received FDA's Breakthrough Device Designation and is currently undergoing pivotal clinical trials to validate its safety and accuracy in patients undergoing GI procedures. Exero Medical targets healthcare providers, hospitals, and surgical teams, offering them real-time data to help prevent severe post-surgical complications. The company has secured significant funding to support its clinical trials and plans for the commercial launch of the xBar system in the US market.

• Employees 13
• Founded 2018
• Total Funding $14000000